Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study

INTRODUCTION: The clinical benefits of insulin glargine 300 U/mL (Gla-300) have been confirmed in randomised clinical trials (EDITION programme and BRIGHT) and real-world studies in the USA and Western Europe. ATOS evaluated the real-world effectiveness and safety of Gla-300 in wider geographic regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Galstyan, Gagik R., Tirosh, Amir, Vargas-Uricoechea, Hernando, Mabunay, Maria Aileen, Coudert, Mathieu, Naqvi, Mubarak, Pilorget, Valerie, Khan, Niaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174390/
https://www.ncbi.nlm.nih.gov/pubmed/35532858
http://dx.doi.org/10.1007/s13300-022-01266-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174390/
https://www.ncbi.nlm.nih.gov/pubmed/35532858
http://dx.doi.org/10.1007/s13300-022-01266-4

Ejemplares similares